Resources

Miller School Leads Groundbreaking Trial Treating Severe COVID-19 with Mesenchymal Stem Cells – University of Miami Miller School of Medicine

University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical-cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine on January 5.
READ MORE

Leave a Reply

Your email address will not be published.